General Information
Product name
Methadone Hydrochloride Oral Solution USP CII (Unflavored or Cherry)
Chemical name
6-(dimethylamino)-4,4-diphenyl-3-hepatanone hydrochloride
CAS No.
1095-90-5
1.2.1 Relevant identified uses
Analgesia and for detoxification or maintenance in opioid addiction
Manufacturer Name
VistaPharm, Inc
Icons in SDS
Company Information
company name
VistaPharm, Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Emergency Overview Physical State: Liquid solution administered orally. Pinkish to red, cherry flavored solution with 10gm/5mL or 5mg/5mL active ingredient. Pinkish to red, cherry flavored solution with 10mg/5mL or 5mg/5mL active ingredient. Odor: No data available. WARNING: Methadone Hydrochloride Oral Solution USP CII is an opioid analgesic. May be harmful if swallowed. Accidental ingestion of large amounts may be fatal.
Principle Routes of Exposure
Ingestion
Potential health effects
Inhalation: Not expected to be an inhalation hazard in final pharmaceutical form. Eye Contact: Not expected to be a hazard to the eye. Contact with eye may cause irritation, burning and redness. Methadone Hydrochloride Oral Solution USP CII – Page 2 of 4 Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions resulting in rash, redness, itching and inflammation. Ingestion: May be harmful if ingested. Can cause respiratory depression, nausea, vomiting, sedation and dizziness. Toxicity Data: See Section 11. Effects of Overexposure: The potential for exposure is reduced in finished pharmaceutical form. Overexposure may cause respiratory depression, extreme somnolence progressing toward stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and constricted pupils. Severe overexposure can cause apnea, circulatory collapse, cardiac arrest and death. Target Organs: Central nervous system.
